Suppr超能文献

[几种生物学标志物对淋巴结阴性乳腺癌患者预后的评估]

[Evaluation of several biological markers in the prognosis of patients with node-negative breast cancer].

作者信息

Zhang B, Li Y, Ma T

机构信息

Liaoning Provincial Tumor Hospital, Shenyang 110042, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2000 Jul;22(4):298-300.

Abstract

OBJECTIVE

To evaluate the practical significance of microvessel count (MVC), c-erbB-2, CD44, cathepsin D and nm23 expression, and clinico-pathological parameters in the prognosis of node-negative breast cancer.

METHODS

Sixty two patients with node-negative invasive breast cancer were treated by surgery alone, and followed-up for at least 10 years. Microvessel count (MVC), C-erbB-2, CD44, Cathepsin D and nm23 expression were studied by immunohistochemical technique. With other clinico-pathological parameters, they were evaluated prognostically.

RESULTS

Univariate analysis showed that the prognostic factors influencing 10-year overall survival rate were MVC, C-erbB-2, stromal cell cath-D and CD44 expression. Multivariate analysis demonstrated that MVC was the sole independent prognostic factor determining 10-year survival.

CONCLUSION

Although MVC, c-erbB-2, stromal cell cath-D and CD44 expression are all of prognostic significance, MVC is most meaningful in evaluating prognosis of node-negative breast cancer patients.

摘要

目的

评估微血管计数(MVC)、c-erbB-2、CD44、组织蛋白酶D和nm23表达以及临床病理参数在腋窝淋巴结阴性乳腺癌预后中的实际意义。

方法

62例腋窝淋巴结阴性浸润性乳腺癌患者仅接受手术治疗,并随访至少10年。采用免疫组织化学技术研究微血管计数(MVC)、C-erbB-2、CD44、组织蛋白酶D和nm23表达。结合其他临床病理参数,对其预后进行评估。

结果

单因素分析显示,影响10年总生存率的预后因素为MVC、C-erbB-2、基质细胞组织蛋白酶D和CD44表达。多因素分析表明,MVC是决定10年生存率的唯一独立预后因素。

结论

虽然MVC、c-erbB-2、基质细胞组织蛋白酶D和CD44表达均具有预后意义,但MVC在评估腋窝淋巴结阴性乳腺癌患者预后方面最具意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验